Company Overview and News
The US private equity firm’s investment in Malaysian death care provider Nirvana Asia marks its first deal in the region outside China
MarketWatch: Even though a steady stream of money has flowed out of US stocks into overseas markets, investors expect European and emerging market equities to rise further, supported by expectations for economic growth and accommodative central bank policies. - Reuters
Gaining control: The move is seen as another milestone and part of Gabungan’s transformation plan by Azizan.
Death care is a potentially lucrative business serving a basic human need. Demographic tailwinds in China are driving massive growth in the fragmented industry.
Government-sponsored infrastructure projects are a boon to domestic construction companies and one such such beneficiary is WZ Satu Bhd, a smallish company with a market capitalisation of about RM404.7mil.
Tags / Keywords: Corporate News , Leadership , Nirvana Asia Ltd , Tan Sri David Kong , Forbes
KUALA LUMPUR (Feb 10): Based on corporate announcements and news flow today, companies that may be in focus on Monday (Feb 13) could include the following: AirAsia X, Westports, Kia Lim, Paramount, MAHB, MWE, OldTown, Excel Force MSC, MISC, 7-Eleven, WZ Satu, TSH Resources and IRIS
PETALING JAYA: The Tang family, who has launched a bid to take The Store Corp Bhd private, has raised the takeover offer price to RM3.70 from RM3.52 previously.
Major transaction: An aerial view of Port of Tanjung Pelepas, which is operated by MMC Corp, in Gelang Patah, Johor. In October last year, MMC Corp offered to buy out Permodalan Nasional Bhd’s 53.42 stake in NCB Holdings Bhd for RM4.40 per share.
KUALA LUMPUR (Dec 23): TYS Consolidated Sdn Bhd has upped its takeover offer for The Store Corp Bhd to RM3.70 per share from RM3.52, valuing the company at RM253.46 million.
KUALA LUMPUR (Nov 4): Based on corporate announcements and news flow today, stocks in focus on Monday (Nov 7) may include: Boustead Holdings Bhd, The Store Corp Bhd, SLP Resources Bhd, Reach Energy Bhd, Malaysia Smelting Corp Bhd (MSC), BHS Industries Bhd and Tenaga Nasional Bhd (TNB).
HONG KONG (Sept 28): A group comprising Kuwait Investment Authority and private equity firm CVC Capital Partners is among final bidders for Sithe Global Power LLC’s stake in a Philippine power plant that could fetch at least US$500 million, people with knowledge of the matter said.
KUALA LUMUPR: Initial public offerings tumbled in the wake of the global financial crisis to 14 in 2009 – the lowest since the super bull-run days of the 1990s. That same year, foreign IPOs were introduced to the local bourse, with the first being XingQuan International Sports Holdings Ltd.
July 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Friday:
Private-equity firm CVC Capital Partners made a buyout offer for Nirvana Asia Ltd., Asia’s largest funeral-services provider by revenue, in a deal worth more than $900 million, according to a person familiar with the situation.
8h - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
8h - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
18h - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...